Dianthus Therapeutics, Inc.Dianthus Therapeutics, Inc.Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

No trades
See on Supercharts

DNTH fundamentals

Dianthus Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of DNTH for the last quarter is 874.00 k USD, and it's 91.25% higher compared to the previous quarter. The net income of Q1 24 is -13.75 M USD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth